Farallon Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$32.7M	Buy	+898,000	New	+$32.7M	0.14%	57
2024 Q4	–	Sell	-4,000	Closed	-$222K	–	161
2024 Q3	$222K	Sell	4,000 -95,000	-96%	-$5.28M	﹤0.01%	133
2024 Q2	$4.07M	Hold	99,000	–	–	0.02%	88
2024 Q1	$4.62M	Buy	+99,000	New	+$4.62M	0.02%	100